The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
about
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Current treatment of locoregional recurrence of melanoma.Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.Outcomes for lymph node-positive cutaneous melanoma over two decades.The evolving role of radiation therapy in the management of malignant melanomaIn vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma.Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanomaFavorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.Impact of age on the management of primary melanoma patients.The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysisAxillary lymph node dissection for malignant melanoma.Role of radiotherapy in melanoma managementHuman Merkel cell polyomavirus: virological background and clinical implications.Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review.Analysis of clinical, dermoscopic and histopathological features of primary melanomas of patients with metastatic disease--a retrospective study at the Department of Dermatology, Medical University of Graz, 2000-2010.Desmoplastic Melanoma: Clinical Behavior and Management Implications.Clinical review of treatment outcomes and patterns of failure with adjuvant radiotherapy in node-positive malignant melanoma.Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis.Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology.Adjuvant Therapy for Melanoma.The Great Debate at "Melanoma Bridge", Napoli, December 2nd, 2017.[Malignant head and neck melanoma: Part 2: Therapy].
P2860
Q26770492-31213A22-D8C4-4E03-91B3-94367A832B12Q34888462-13019B2C-0A5F-47B4-8C0F-D0D4B51A7BEDQ34986199-D0C29829-BE7D-43B3-8737-0B3890078AF7Q35028465-4F569E2E-54BF-4546-91B9-4336ED48766DQ35056773-62162464-5CA7-4DA4-84C9-7B502A97E9B5Q35130444-2A1DA201-E479-464A-9AF9-D01993ED9789Q35221682-00BA9FCF-5FA0-46C7-9A08-6A8805C0AC56Q36082506-31A9FEE3-7271-42C5-BB47-39AAD922DA61Q36279410-E2DDA983-963D-4856-86D7-3C4705297412Q36597517-7CD21226-ABD9-4514-A492-7E0026C33C8BQ37346993-47AB6AF8-54CA-45FD-8514-AB5820FA0611Q37729387-D8CB18FC-6FB7-4EEB-8DE5-B160CFF46AF3Q37980464-604D0C7A-FB55-43EB-B3BC-6E057CF0E9F5Q38039069-3E4F493E-9ECD-4D09-B878-2C6545804F25Q38115562-30160102-AF9A-4BFB-868B-4EABEFD110F6Q38151728-A83D0E7B-63AC-4273-AB69-51F9496C4CA1Q38191703-A0BA52B3-3492-41B5-9094-4157B7453FADQ38713635-402F1950-1514-4631-96E1-BC5E38692AF0Q38964357-F7159B07-8F8D-43B5-85CD-69509725164EQ38994394-59790DF2-E667-458E-9A1D-28EDB6776EBCQ44578453-2EC10734-3EFC-4AEE-8DE5-8A34B80FFC2FQ47437659-50F65F5D-72D6-49B5-A421-68A9EE139B85Q48831498-014B22AD-29B3-4CBC-8949-6AAC6FEC5590Q51052594-9FF50444-3AD2-41D0-9B01-2131D9FBD5BDQ52582484-102852DE-9441-4070-A5CA-08805B05CB48Q54256327-83BC41A6-2D18-4667-BDF2-131EAAC33C77
P2860
The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@ast
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@en
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@nl
type
label
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@ast
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@en
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@nl
prefLabel
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@ast
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@en
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@nl
P2093
P921
P356
P1433
P1476
The benefits of adjuvant radia ...... ymph node-metastatic melanoma.
@en
P2093
Beverly A Guadagnolo
John M Kane
William G Kraybill
P2860
P304
P356
10.1002/CNCR.24627
P407
P577
2009-12-01T00:00:00Z